PROVIDENCE, R.I.--(BUSINESS WIRE)--Apr 2, 2012-- Ximedica today announced that it has been named as a supplier to a finalist product in the 2012 Medical Design Excellence Awards (MDEA) competition. The honor comes in recognition of their work on Cohera Medical's TissuGlu(R)Surgical Adhesive applicator.
Cohera Medical, Inc.(R) engaged Ximedica's services to design and engineer an applicator that easily and effectively dispenses surgical adhesive intended to bond large planar flaps of tissue together after large flap surgeries like abdominoplasty.
The MDEA is the medical device industry's premier design awards competition and is the only awards program that exclusively recognizes contributions and advances in the design of medical products. Entries are evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges so that the product meets its clinical objectives.
A comprehensive review of the entries was performed by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, human factors, industrial design, medicine, and diagnostics.
"We are delighted to have our development work recognized," states Aidan Petrie , Chief Innovation Officer of Ximedica, "and to have supported Cohera in the realization of this product." About Ximedica Ximedica provides human-centered research, product development, regulatory, and introductory manufacturing services to leading medical and healthcare companies. Our goal is to help clients create and sustain profitable new business by providing commercially successful product. Ximedica is ISO 13485:2003 certified and FDA registered, with headquarters in Providence, Rhode Island and offices in Minnesota and Hong Kong. www.ximedica.com About Cohera Medical Cohera Medical, Inc.(R) is a leading innovator and developer of absorbable surgical adhesives and sealants. TissuGlu(R) has received CE Marking approval to be sold in the European Union (EU). Outside of the EU, TissuGlu is currently indicated for investigational use only and has not yet been approved for sale or marketing by the Food and Drug Administration (FDA) in the U.S. or in any other market. For more information, visit www.coheramed.com.
Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.
CONTACT: Ximedica Hope Hopkins, 401-330-3163, x149 Director of Communications firstname.lastname@example.org KEYWORD: UNITED STATES NORTH AMERICA RHODE ISLAND INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY MEDICAL DEVICES OTHER HEALTH MEDICAL SUPPLIES GENERAL HEALTH SOURCE: Ximedica Copyright Business Wire 2012 PUB: 04/02/2012 11:37 AM/DISC: 04/02/2012 11:37 AM http://www.businesswire.com/news/home/20120402006307/